Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enfuvirtide Maintenance in HIV-1
NCT02733419Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2004
- Primary completion
- Mar 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Started Dec 2004; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02733419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733419.